Mean progression between groups did not differ according to scores on the Neurological Examination Score for the Assessment of Spinocerebellar Ataxia ( NESSCA ) after 48 weeks ( -0.35 ; 95 % confidence interval , -1.7 to 1.0 ; primary efficacy outcome ) .